AEGR

Aegerion Pharmaceuticals, Inc.CIK 1338042 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for AEGR PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for AEGR

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Buono Linda	Sr. VP, Human Resources	3	$0	$0	2016-11-29
Chan Barbara Y	VP, Chief Accounting Officer	2	$0	$0	2016-11-29
Louis Roger	See Remarks	6	$0	$0	2016-11-29
Harshbarger Benjamin	General Counsel and Secretary	26	$0	$0	2016-11-29
Stern Donald K	Director	2	$0	$0	2016-11-29
Plutzky Jorge MD	Director	2	$0	$0	2016-11-29
Broadfin Healthcare Master Fund Ltd	10% Owner	2	$131.3K	$0	2016-11-29
Szela Mary T	Chief Executive Officer	6	$0	$0	2016-11-29
Scheer David	Director	17	$0	$1.69M	2016-11-29
BARER SOL J	Director	11	$0	$0	2016-11-29
SMITH SANDFORD D	Director	30	$0	$1.16M	2016-11-29
PERRY GREGORY D	See Remarks	10	$0	$0	2016-11-29
VANLENT ANNE	Director	10	$135.1K	$0	2016-11-29
THOMAS PAUL	Director	11	$0	$0	2016-11-29
GOTTO ANTONIO M JR MD D PHIL	Director	11	$0	$0	2016-11-29
Broadfin Capital, LLC	10% Owner	3	$459.2K	$0	2016-09-12
Carter Martha J.	See Remarks	15	$27.9K	$414.1K	2016-05-09
KOTLER KEVIN	10% Owner	7	$439.6K	$0	2016-03-18
Weger Mary	Chief Performance Officer	3	$0	$0	2015-08-04
Andrews William T.	See Remarks	3	$0	$0	2015-08-04
Sumeray Mark	Chief Medical Officer	83	$0	$3.13M	2015-08-04
Cook Anne Marie	SVP, General Counsel	7	$0	$0	2015-08-04
Fraser Craig	Pres., US/Int. Comm. & Manuf.	38	$0	$2.72M	2015-04-01
Fitzpatrick Mark J.	Chief Financial Officer	33	$42.3K	$1.76M	2015-04-01
Beer Marc D	Chief Executive Officer	47	$2.35M	$8.82M	2015-04-01
PERCEPTIVE ADVISORS LLC	10% Owner	15	$16.28M	$66.90M	2013-09-05
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD	10% Owner	6	$4.57M	$0	2013-01-18
EDELMAN JOSEPH	10% Owner	3	$425.4K	$0	2012-12-04
HURWITZ EDWARD	10% Owner	6	$0	$3.68M	2012-10-16
Rothera Mark	Global President	2	$0	$0	2012-06-01
Advent Healthcare & Life Sciences III-A Limited Partnership	Other	4	$0	$1.69M	2012-03-09
Advent Partners HLS III Limited Partnership	Other	4	$0	$31.7K	2012-03-09
ADVENT HEALTHCARE & LIFE SCIENCES III LIMITED PARTNERSHIP	Other	4	$0	$1.15M	2012-03-09
AHLS III GP LIMITED PARTNERSHIP	Other	4	$0	$2.84M	2012-03-09
ADVENT INTERNATIONAL LLC	Other	4	$0	$2.84M	2012-03-09
ADVENT INTERNATIONAL CORP/MA	Other	4	$0	$2.87M	2012-03-09
Yucca Partners L.P. Jersey Branch	10% Owner	1	$0	$854.0K	2012-01-30

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
BARER SOL J	Director	D To issuer deriv	2016-11-29	2016-11-30	14,700	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2016-11-29	2016-11-30	19,927	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2016-11-29	2016-11-30	9,988	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2016-11-29	2016-11-30	12,854	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2016-11-29	2016-11-30	5,012	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer deriv	2016-11-29	2016-11-30	18,000	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2016-11-29	2016-11-30	14,700	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2016-11-29	2016-11-30	5,012	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2016-11-29	2016-11-30	18,000	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2016-11-29	2016-11-30	9,988	—	$0	0	SEC↗
Scheer David	Director	D To issuer deriv	2016-11-29	2016-11-30	12,854	—	$0	0	SEC↗
GOTTO ANTONIO M JR MD D PHIL	Director	D To issuer deriv	2016-11-29	2016-11-30	10,238	—	$0	0	SEC↗
GOTTO ANTONIO M JR MD D PHIL	Director	D To issuer deriv	2016-11-29	2016-11-30	18,000	—	$0	0	SEC↗
GOTTO ANTONIO M JR MD D PHIL	Director	D To issuer deriv	2016-11-29	2016-11-30	5,012	—	$0	0	SEC↗
GOTTO ANTONIO M JR MD D PHIL	Director	D To issuer deriv	2016-11-29	2016-11-30	14,700	—	$0	0	SEC↗
GOTTO ANTONIO M JR MD D PHIL	Director	D To issuer deriv	2016-11-29	2016-11-30	12,854	—	$0	0	SEC↗
GOTTO ANTONIO M JR MD D PHIL	Director	D To issuer deriv	2016-11-29	2016-11-30	9,988	—	$0	0	SEC↗
SMITH SANDFORD D	Director	D To issuer deriv	2016-11-29	2016-11-30	40,000	—	$0	0	SEC↗
SMITH SANDFORD D	Director	D To issuer deriv	2016-11-29	2016-11-30	18,000	—	$0	0	SEC↗
SMITH SANDFORD D	Director	D To issuer deriv	2016-11-29	2016-11-30	5,012	—	$0	0	SEC↗
SMITH SANDFORD D	Director	D To issuer deriv	2016-11-29	2016-11-30	14,700	—	$0	0	SEC↗
SMITH SANDFORD D	Director	D To issuer deriv	2016-11-29	2016-11-30	16,435	—	$0	0	SEC↗
SMITH SANDFORD D	Director	D To issuer deriv	2016-11-29	2016-11-30	8,569	—	$0	0	SEC↗
SMITH SANDFORD D	Director	D To issuer deriv	2016-11-29	2016-11-30	8,888	—	$0	0	SEC↗
Stern Donald K	Director	D To issuer deriv	2016-11-29	2016-11-30	31,182	—	$0	0	SEC↗
Szela Mary T	Chief Executive Officer	D To issuer deriv	2016-11-29	2016-11-30	600,000	—	$0	0	SEC↗
Szela Mary T	Chief Executive Officer	D To issuer deriv	2016-11-29	2016-11-30	194,000	—	$0	0	SEC↗
Szela Mary T	Chief Executive Officer	D To issuer deriv	2016-11-29	2016-11-30	97,000	—	$0	0	SEC↗
THOMAS PAUL	Director	D To issuer deriv	2016-11-29	2016-11-30	12,854	—	$0	0	SEC↗
THOMAS PAUL	Director	D To issuer deriv	2016-11-29	2016-11-30	14,700	—	$0	0	SEC↗
THOMAS PAUL	Director	D To issuer deriv	2016-11-29	2016-11-30	5,012	—	$0	0	SEC↗
THOMAS PAUL	Director	D To issuer deriv	2016-11-29	2016-11-30	18,000	—	$0	0	SEC↗
THOMAS PAUL	Director	D To issuer deriv	2016-11-29	2016-11-30	23,521	—	$0	0	SEC↗
VANLENT ANNE	Director	D To issuer deriv	2016-11-29	2016-11-30	14,700	—	$0	0	SEC↗
VANLENT ANNE	Director	D To issuer deriv	2016-11-29	2016-11-30	5,012	—	$0	0	SEC↗
VANLENT ANNE	Director	D To issuer deriv	2016-11-29	2016-11-30	18,000	—	$0	0	SEC↗
Buono Linda	Sr. VP, Human Resources	D To issuer deriv	2016-11-29	2016-11-30	75,000	—	$0	0	SEC↗
Buono Linda	Sr. VP, Human Resources	D To issuer deriv	2016-11-29	2016-11-30	7,000	—	$0	0	SEC↗
Buono Linda	Sr. VP, Human Resources	D To issuer deriv	2016-11-29	2016-11-30	4,000	—	$0	0	SEC↗
Chan Barbara Y	VP, Chief Accounting Officer	D To issuer deriv	2016-11-29	2016-11-30	26,000	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	2,500	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	1,733	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	3,500	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	3,282	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	30,000	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	3,399	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	1,701	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	14,324	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	2,676	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	10,683	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	1,817	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	15,096	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	25,529	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	7,300	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer deriv	2016-11-29	2016-11-30	5,100	—	$0	0	SEC↗
Louis Roger	Chief Compliance Officer	D To issuer deriv	2016-11-29	2016-11-30	8,000	—	$0	0	SEC↗
Louis Roger	Chief Compliance Officer	D To issuer deriv	2016-11-29	2016-11-30	85,000	—	$0	0	SEC↗
Louis Roger	Chief Compliance Officer	D To issuer deriv	2016-11-29	2016-11-30	17,000	—	$0	0	SEC↗
PERRY GREGORY D	Other	D To issuer deriv	2016-11-29	2016-11-30	40,000	—	$0	0	SEC↗
PERRY GREGORY D	Other	D To issuer deriv	2016-11-29	2016-11-30	200,000	—	$0	0	SEC↗
PERRY GREGORY D	Other	D To issuer deriv	2016-11-29	2016-11-30	35,000	—	$0	0	SEC↗
PERRY GREGORY D	Other	D To issuer deriv	2016-11-29	2016-11-30	200,000	—	$0	0	SEC↗
PERRY GREGORY D	Other	D To issuer deriv	2016-11-29	2016-11-30	69,000	—	$0	0	SEC↗
Plutzky Jorge MD	Director	D To issuer deriv	2016-11-29	2016-11-30	31,182	—	$0	0	SEC↗
BARER SOL J	Director	D To issuer	2016-11-29	2016-11-30	29,890	—	$0	0	SEC↗
Scheer David	Director	D To issuer	2016-11-29	2016-11-30	521,350	—	$0	0	SEC↗
Scheer David	Director	D To issuer	2016-11-29	2016-11-30	10,000	—	$0	0	SEC↗
GOTTO ANTONIO M JR MD D PHIL	Director	D To issuer	2016-11-29	2016-11-30	13,916	—	$0	0	SEC↗
SMITH SANDFORD D	Director	D To issuer	2016-11-29	2016-11-30	2,890	—	$0	0	SEC↗
THOMAS PAUL	Director	D To issuer	2016-11-29	2016-11-30	36,978	—	$0	0	SEC↗
VANLENT ANNE	Director	D To issuer	2016-11-29	2016-11-30	4,000	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	D To issuer	2016-11-29	2016-11-30	1,704	—	$0	0	SEC↗
Broadfin Healthcare Master Fun	10% Owner	D To issuer	2016-11-29	2016-12-01	4,361,291	—	$0	0	SEC↗
Harshbarger Benjamin	General Counsel	M Exercise deriv	2016-09-17	2016-09-20	1,642	—	$0	3,282	SEC↗
Harshbarger Benjamin	General Counsel	M Exercise	2016-09-17	2016-09-20	1,642	—	$0	2,236	SEC↗
Harshbarger Benjamin	General Counsel	F Tax w/h	2016-09-17	2016-09-20	532	$1.78	$947	1,704	SEC↗
Broadfin Healthcare Master Fun	10% Owner	P Buy	2016-09-13	2016-09-14	75,000	$1.75	$131.3K	4,361,291	SEC↗
Broadfin Capital, LLC	10% Owner	P Buy	2016-09-12	2016-09-12	76,000	$1.70	$129.2K	4,286,291	SEC↗
Broadfin Capital, LLC	10% Owner	P Buy	2016-09-12	2016-09-12	100,000	$1.70	$170.0K	4,210,291	SEC↗
Broadfin Capital, LLC	10% Owner	P Buy	2016-09-09	2016-09-12	100,000	$1.60	$160.0K	4,110,291	SEC↗
SMITH SANDFORD D	Director	M Exercise deriv	2016-07-27	2016-07-29	2,222	—	$0	8,888	SEC↗
SMITH SANDFORD D	Director	F Tax w/h	2016-07-27	2016-07-29	777	$1.55	$1.2K	2,890	SEC↗
SMITH SANDFORD D	Director	M Exercise	2016-07-27	2016-07-29	2,222	—	$0	3,667	SEC↗
Chan Barbara Y	VP, Chief Accounting Officer	A Award deriv	2016-07-01	2016-07-05	26,000	—	$0	26,000	SEC↗
Carter Martha J.	See Remarks	A Award deriv	2016-05-09	2016-05-11	13,000	—	$0	13,000	SEC↗
Carter Martha J.	See Remarks	A Award deriv	2016-05-09	2016-05-11	26,000	—	$0	26,000	SEC↗
Szela Mary T	Chief Executive Officer	A Award deriv	2016-05-09	2016-05-11	194,000	—	$0	194,000	SEC↗
Szela Mary T	Chief Executive Officer	A Award deriv	2016-05-09	2016-05-11	97,000	—	$0	97,000	SEC↗
Louis Roger	Chief Compliance Officer	A Award deriv	2016-05-09	2016-05-11	8,000	—	$0	8,000	SEC↗
Louis Roger	Chief Compliance Officer	A Award deriv	2016-05-09	2016-05-11	17,000	—	$0	17,000	SEC↗
PERRY GREGORY D	See Remarks	A Award deriv	2016-05-09	2016-05-11	35,000	—	$0	35,000	SEC↗
PERRY GREGORY D	See Remarks	A Award deriv	2016-05-09	2016-05-11	69,000	—	$0	69,000	SEC↗
Harshbarger Benjamin	Acting General Counsel	A Award deriv	2016-05-09	2016-05-11	5,100	—	$0	5,100	SEC↗
Harshbarger Benjamin	Acting General Counsel	A Award deriv	2016-05-09	2016-05-11	7,300	—	$0	7,300	SEC↗
Harshbarger Benjamin	General Counsel	M Exercise deriv	2016-04-01	2016-09-20	867	—	$0	1,733	SEC↗
Harshbarger Benjamin	General Counsel	M Exercise	2016-04-01	2016-09-20	867	—	$0	867	SEC↗
Harshbarger Benjamin	General Counsel	F Tax w/h	2016-04-01	2016-09-20	273	$3.55	$969	594	SEC↗
KOTLER KEVIN	10% Owner	E Expire deriv	2016-03-18	2016-03-21	5,000	—	$0	0	SEC↗
KOTLER KEVIN	10% Owner	X Exercise deriv	2016-03-18	2016-03-21	4,976	—	$0	0	SEC↗
KOTLER KEVIN	10% Owner	X Exercise	2016-03-18	2016-03-21	497,600	$7.50	$3.73M	4,010,291	SEC↗
KOTLER KEVIN	10% Owner	X Exercise deriv	2016-03-17	2016-03-21	24	—	$0	0	SEC↗
KOTLER KEVIN	10% Owner	X Exercise	2016-03-17	2016-03-21	2,400	$7.50	$18.0K	3,512,691	SEC↗
PERRY GREGORY D	See Remarks	A Award deriv	2016-02-12	2016-02-17	200,000	—	$0	200,000	SEC↗
SMITH SANDFORD D	Director	M Exercise deriv	2016-01-27	2016-01-29	2,223	—	$0	11,110	SEC↗
SMITH SANDFORD D	Director	F Tax w/h	2016-01-27	2016-01-29	778	$6.78	$5.3K	1,445	SEC↗
SMITH SANDFORD D	Director	M Exercise	2016-01-27	2016-01-29	2,223	—	$0	2,223	SEC↗
Szela Mary T	Chief Executive Officer	A Award deriv	2016-01-07	2016-01-11	600,000	—	$0	600,000	SEC↗
Louis Roger	See Remarks	A Award deriv	2015-12-01	2015-12-02	85,000	—	$0	85,000	SEC↗
Scheer David	Director	J Other	2015-12-01	2015-12-03	1,855	—	$0	585,364	SEC↗
Scheer David	Director	J Other	2015-12-01	2015-12-03	64,014	—	$0	521,350	SEC↗
KOTLER KEVIN	10% Owner	P Buy	2015-11-11	2015-11-13	5,100	$10.99	$56.0K	3,975,291	SEC↗
KOTLER KEVIN	10% Owner	P Buy	2015-11-11	2015-11-13	35,000	$10.96	$383.6K	4,010,291	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	A Award deriv	2015-10-01	2015-10-05	30,000	—	$0	30,000	SEC↗
Harshbarger Benjamin	General Counsel and Secretar	A Award deriv	2015-09-17	2015-09-18	4,924	—	$0	4,924	SEC↗
Stern Donald K	Director	A Award deriv	2015-09-17	2015-09-18	31,182	—	$0	31,182	SEC↗
SMITH SANDFORD D	Chief Executive Officer	A Award deriv	2015-08-21	2015-08-25	13,333	—	$0	13,333	SEC↗
SMITH SANDFORD D	Chief Executive Officer	A Award deriv	2015-08-21	2015-08-25	40,000	—	$0	40,000	SEC↗
Cook Anne Marie	SVP, General Counsel	A Award deriv	2015-08-04	2015-08-06	40,000	—	$0	40,000	SEC↗
Andrews William T.	See Remarks	A Award deriv	2015-08-04	2015-08-06	40,000	—	$0	40,000	SEC↗
Sumeray Mark	Chief Medical Officer	A Award deriv	2015-08-04	2015-08-06	40,000	—	$0	40,000	SEC↗
Carter Martha J.	See Remarks	A Award deriv	2015-08-04	2015-08-06	40,000	—	$0	40,000	SEC↗
Weger Mary	Chief Performance Officer	A Award deriv	2015-08-04	2015-08-06	40,000	—	$0	40,000	SEC↗
PERRY GREGORY D	Chief Financial Officer	A Award deriv	2015-08-04	2015-08-06	40,000	—	$0	40,000	SEC↗
PERRY GREGORY D	Chief Financial Officer	A Award deriv	2015-08-03	2015-08-04	200,000	—	$0	200,000	SEC↗
BARER SOL J	Director	A Award deriv	2015-06-26	2015-06-29	18,000	—	$0	18,000	SEC↗
Scheer David	Director	A Award deriv	2015-06-26	2015-06-29	18,000	—	$0	18,000	SEC↗
THOMAS PAUL	Director	A Award deriv	2015-06-26	2015-06-29	18,000	—	$0	18,000	SEC↗
GOTTO ANTONIO M JR MD D PHIL	Director	A Award deriv	2015-06-26	2015-06-29	18,000	—	$0	18,000	SEC↗
VANLENT ANNE	Director	A Award deriv	2015-06-26	2015-06-29	18,000	—	$0	18,000	SEC↗
SMITH SANDFORD D	Director	A Award deriv	2015-06-26	2015-06-29	18,000	—	$0	18,000	SEC↗
Carter Martha J.	See Remarks	A Award deriv	2015-05-01	2015-05-07	13,000	—	$0	13,000	SEC↗
Carter Martha J.	See Remarks	A Award deriv	2015-05-01	2015-05-07	3,000	—	$0	3,000	SEC↗
Plutzky Jorge MD	Director	A Award deriv	2015-04-08	2015-04-10	31,182	—	$0	31,182	SEC↗
Cook Anne Marie	SVP, General Counsel	A Award deriv	2015-04-01	2015-04-03	10,000	—	$0	10,000	SEC↗
Cook Anne Marie	SVP, General Counsel	A Award deriv	2015-04-01	2015-04-03	40,000	—	$0	40,000	SEC↗
Sumeray Mark	Chief Medical Officer	A Award deriv	2015-04-01	2015-04-03	40,000	—	$0	40,000	SEC↗
Sumeray Mark	Chief Medical Officer	A Award deriv	2015-04-01	2015-04-03	10,000	—	$0	10,000	SEC↗
Fraser Craig	Chief Operating Officer	A Award deriv	2015-04-01	2015-04-03	9,000	—	$0	9,000	SEC↗
Fraser Craig	Chief Operating Officer	A Award deriv	2015-04-01	2015-04-03	37,000	—	$0	37,000	SEC↗
Carter Martha J.	See Remarks	A Award deriv	2015-04-01	2015-04-03	27,000	—	$0	27,000	SEC↗
Carter Martha J.	See Remarks	A Award deriv	2015-04-01	2015-04-03	7,000	—	$0	7,000	SEC↗
Beer Marc D	Chief Executive Officer	A Award deriv	2015-04-01	2015-04-03	33,000	—	$0	33,000	SEC↗
Beer Marc D	Chief Executive Officer	A Award deriv	2015-04-01	2015-04-03	133,000	—	$0	133,000	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	A Award deriv	2015-04-01	2015-04-03	40,000	—	$0	40,000	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	A Award deriv	2015-04-01	2015-04-03	10,000	—	$0	10,000	SEC↗
Andrews William T.	See Remarks	A Award deriv	2015-04-01	2015-04-03	27,000	—	$0	27,000	SEC↗
Andrews William T.	See Remarks	A Award deriv	2015-04-01	2015-04-03	7,000	—	$0	7,000	SEC↗
Weger Mary	Chief Performance Officer	A Award deriv	2015-04-01	2015-04-03	7,000	—	$0	7,000	SEC↗
Weger Mary	Chief Performance Officer	A Award deriv	2015-04-01	2015-04-03	27,000	—	$0	27,000	SEC↗
Fraser Craig	Chief Operating Officer	A Award deriv	2014-12-31	2015-01-05	45,000	—	$0	45,000	SEC↗
Carter Martha J.	See Remarks	A Award deriv	2014-12-31	2015-01-05	65,000	—	$0	65,000	SEC↗
Sumeray Mark	Chief Medical Officer	A Award deriv	2014-12-31	2015-01-05	65,000	—	$0	65,000	SEC↗
Beer Marc D	Chief Executive Officer	A Award deriv	2014-12-31	2015-01-05	120,000	—	$0	120,000	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	A Award deriv	2014-12-31	2015-01-05	65,000	—	$0	65,000	SEC↗
Cook Anne Marie	SVP, General Counsel	A Award deriv	2014-12-31	2015-01-05	45,000	—	$0	45,000	SEC↗
Beer Marc D	Chief Executive Officer	G Gift	2014-08-28	2014-09-02	769	—	$0	78,631	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	P Buy	2014-08-19	2014-08-20	1,150	$30.64	$35.2K	9,500	SEC↗
Fraser Craig	Chief Operating Officer	A Award deriv	2014-08-01	2014-08-04	50,000	—	$0	50,000	SEC↗
Beer Marc D	Chief Executive Officer	P Buy	2014-07-31	2014-07-31	2,300	$34.37	$79.1K	79,400	SEC↗
Beer Marc D	Chief Executive Officer	P Buy	2014-07-31	2014-07-31	7,700	$33.44	$257.5K	77,100	SEC↗
SMITH SANDFORD D	Director	A Award deriv	2014-06-26	2014-06-30	5,012	—	$0	5,012	SEC↗
THOMAS PAUL	Director	A Award deriv	2014-06-26	2014-06-30	5,012	—	$0	5,012	SEC↗
VANLENT ANNE	Director	A Award deriv	2014-06-26	2014-06-30	5,012	—	$0	5,012	SEC↗
BARER SOL J	Director	A Award deriv	2014-06-26	2014-06-30	5,012	—	$0	5,012	SEC↗
Scheer David	Director	A Award deriv	2014-06-26	2014-06-30	5,012	—	$0	5,012	SEC↗
GOTTO ANTONIO M JR MD D PHIL	Director	A Award deriv	2014-06-26	2014-06-30	5,012	—	$0	5,012	SEC↗
Beer Marc D	Chief Executive Officer	P Buy	2014-06-03	2014-06-04	10,000	$30.12	$301.2K	69,400	SEC↗
Beer Marc D	Chief Executive Officer	P Buy	2014-05-27	2014-05-27	10,000	$31.59	$315.9K	59,400	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise deriv	2014-05-21	2014-05-22	6,400	—	$0	732,873	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise	2014-05-21	2014-05-22	6,400	$1.54	$9.9K	49,400	SEC↗
Beer Marc D	Chief Executive Officer	P Buy	2014-05-20	2014-05-21	10,000	$30.53	$305.3K	43,000	SEC↗
Beer Marc D	Chief Executive Officer	P Buy	2014-05-08	2014-05-08	30,000	$35.31	$1.06M	33,000	SEC↗
VANLENT ANNE	Director	P Buy	2014-05-08	2014-05-09	52	$35.29	$1.8K	4,000	SEC↗
VANLENT ANNE	Director	P Buy	2014-05-08	2014-05-09	1,948	$34.33	$66.9K	3,948	SEC↗
VANLENT ANNE	Director	P Buy	2014-05-08	2014-05-09	2,000	$33.20	$66.4K	2,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise deriv	2014-04-30	2014-05-01	2,250	—	$0	66,500	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2014-04-30	2014-05-01	1,171	$43.90	$51.4K	0	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise	2014-04-30	2014-05-01	2,250	$13.01	$29.3K	2,250	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2014-04-30	2014-05-01	1,079	$43.18	$46.6K	1,171	SEC↗
Cook Anne Marie	SVP, General Counsel	A Award deriv	2014-04-01	2014-04-21	13,000	—	$0	13,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	A Award deriv	2014-04-01	2014-04-21	20,000	—	$0	20,000	SEC↗
Carter Martha J.	See Remarks	A Award deriv	2014-04-01	2014-04-21	13,000	—	$0	13,000	SEC↗
Beer Marc D	Chief Executive Officer	A Award deriv	2014-04-01	2014-04-21	75,000	—	$0	75,000	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	A Award deriv	2014-04-01	2014-04-21	20,000	—	$0	20,000	SEC↗
Sumeray Mark	Chief Medical Officer	A Award deriv	2014-04-01	2014-04-21	20,000	—	$0	20,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise deriv	2014-03-31	2014-04-02	2,250	—	$0	68,750	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2014-03-31	2014-04-02	100	$47.20	$4.7K	0	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2014-03-31	2014-04-02	1,001	$46.51	$46.6K	100	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2014-03-31	2014-04-02	1,149	$45.84	$52.7K	1,101	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise	2014-03-31	2014-04-02	2,250	$13.01	$29.3K	2,250	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise deriv	2014-03-26	2014-03-27	3,000	—	$0	739,273	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise	2014-03-26	2014-03-27	3,000	$1.54	$4.6K	3,000	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2014-03-14	2014-03-18	2,000	—	$0	113,000	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2014-03-14	2014-03-18	800	$51.98	$41.6K	0	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2014-03-14	2014-03-18	900	$51.31	$46.2K	800	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2014-03-14	2014-03-18	300	$49.69	$14.9K	1,700	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2014-03-14	2014-03-18	2,000	$13.01	$26.0K	2,000	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	M Exercise deriv	2014-03-04	2014-03-05	2,500	—	$0	189,650	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	M Exercise	2014-03-04	2014-03-05	2,500	$17.64	$44.1K	8,350	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2014-02-14	2014-02-18	2,000	—	$0	115,000	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2014-02-14	2014-02-18	500	$64.52	$32.3K	0	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2014-02-14	2014-02-18	1,500	$63.14	$94.7K	500	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2014-02-14	2014-02-18	2,000	$13.01	$26.0K	2,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise deriv	2014-02-11	2014-02-12	2,250	—	$0	71,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2014-02-11	2014-02-12	2,250	$67.00	$150.8K	0	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise	2014-02-11	2014-02-12	2,250	$13.01	$29.3K	2,250	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	M Exercise deriv	2014-02-10	2014-02-12	7,500	—	$0	192,150	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2014-02-10	2014-02-12	486	$64.69	$31.4K	5,850	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2014-02-10	2014-02-12	3,300	$61.71	$203.6K	10,050	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	M Exercise	2014-02-10	2014-02-12	7,500	$17.64	$132.3K	13,350	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2014-02-10	2014-02-12	900	$63.72	$57.3K	6,336	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2014-02-10	2014-02-12	2,814	$62.94	$177.1K	7,236	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2014-01-16	2014-01-21	2,000	—	$0	117,000	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2014-01-16	2014-01-21	100	$59.51	$6.0K	0	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2014-01-16	2014-01-21	1,900	$58.59	$111.3K	100	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2014-01-16	2014-01-21	2,000	$13.01	$26.0K	2,000	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2014-01-02	2014-01-06	1,000	—	$0	119,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise deriv	2014-01-02	2014-01-06	2,250	—	$0	73,250	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2014-01-02	2014-01-06	400	$70.22	$28.1K	600	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2014-01-02	2014-01-06	1,000	$13.01	$13.0K	1,000	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2014-01-02	2014-01-06	600	$71.41	$42.8K	0	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2014-01-02	2014-01-06	1,350	$71.42	$96.4K	0	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise	2014-01-02	2014-01-06	2,250	$13.01	$29.3K	2,250	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2014-01-02	2014-01-06	900	$70.65	$63.6K	1,350	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2013-12-16	2013-12-17	2,000	—	$0	120,000	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-12-16	2013-12-17	200	$67.38	$13.5K	0	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-12-16	2013-12-17	1,800	$66.23	$119.2K	200	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2013-12-16	2013-12-17	2,000	$13.01	$26.0K	2,000	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise deriv	2013-12-04	2013-12-06	4,380	—	$0	742,273	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise	2013-12-04	2013-12-06	4,380	$1.54	$6.7K	4,380	SEC↗
Beer Marc D	Chief Executive Officer	G Gift	2013-12-04	2013-12-06	4,380	—	$0	0	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise deriv	2013-12-02	2013-12-04	2,250	—	$0	75,500	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2013-12-02	2013-12-04	3,000	—	$0	122,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2013-12-02	2013-12-04	1,550	$70.10	$108.7K	700	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2013-12-02	2013-12-04	700	$71.10	$49.8K	0	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise	2013-12-02	2013-12-04	2,250	$13.01	$29.3K	2,250	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-12-02	2013-12-04	600	$71.20	$42.7K	0	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2013-12-02	2013-12-04	3,000	$13.01	$39.0K	3,000	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-12-02	2013-12-04	2,400	$70.23	$168.6K	600	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2013-11-15	2013-11-19	2,000	—	$0	125,000	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2013-11-15	2013-11-19	2,000	$13.01	$26.0K	2,000	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-11-15	2013-11-19	1,011	$75.89	$76.7K	500	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-11-15	2013-11-19	489	$74.93	$36.6K	1,511	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-11-15	2013-11-19	500	$77.63	$38.8K	0	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	M Exercise deriv	2013-11-13	2013-11-13	2,850	—	$0	199,650	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	M Exercise deriv	2013-11-11	2013-11-13	7,500	—	$0	202,500	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2013-11-11	2013-11-13	622	$78.38	$48.8K	9,278	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2013-11-11	2013-11-13	200	$74.43	$14.9K	10,100	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2013-11-11	2013-11-13	200	$73.01	$14.6K	10,300	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	M Exercise	2013-11-11	2013-11-13	7,500	$17.64	$132.3K	10,500	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2013-11-11	2013-11-13	4,478	$79.34	$355.3K	4,800	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2013-11-11	2013-11-13	1,800	$80.03	$144.1K	3,000	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	M Exercise	2013-11-11	2013-11-13	2,850	$17.64	$50.3K	5,850	SEC↗
Fitzpatrick Mark J.	Chief Financial Officer	S Sale	2013-11-11	2013-11-13	200	$76.14	$15.2K	9,900	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise deriv	2013-11-05	2013-11-06	39,000	—	$0	746,653	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise	2013-11-05	2013-11-06	39,000	$1.54	$60.1K	234,726	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise deriv	2013-11-01	2013-11-05	2,250	—	$0	77,750	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2013-11-01	2013-11-05	3,500	—	$0	127,000	SEC↗
Carter Martha J.	Chief Regulatory Officer & S	M Exercise deriv	2013-11-01	2013-11-05	5,000	—	$0	127,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2013-11-01	2013-11-05	300	$82.28	$24.7K	1,950	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise	2013-11-01	2013-11-05	2,250	$13.01	$29.3K	2,250	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2013-11-01	2013-11-05	1,550	$83.22	$129.0K	400	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2013-11-01	2013-11-05	400	$83.99	$33.6K	0	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-11-01	2013-11-05	100	$84.34	$8.4K	0	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-11-01	2013-11-05	2,000	$83.59	$167.2K	100	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2013-11-01	2013-11-05	3,500	$13.01	$45.5K	3,500	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-11-01	2013-11-05	1,400	$82.76	$115.9K	2,100	SEC↗
Carter Martha J.	Chief Regulatory Officer & S	S Sale	2013-11-01	2013-11-05	5,000	$82.81	$414.1K	1,500	SEC↗
Carter Martha J.	Chief Regulatory Officer & S	M Exercise	2013-11-01	2013-11-05	5,000	$14.84	$74.2K	6,500	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise deriv	2013-10-30	2013-10-31	40,000	—	$0	785,653	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	3,800	$89.01	$338.2K	203,726	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	6,019	$87.83	$528.6K	207,526	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	10,000	$87.08	$870.8K	213,545	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	2,314	$85.94	$198.9K	223,545	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	7,067	$85.00	$600.7K	225,859	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	2,800	$84.15	$235.6K	232,926	SEC↗
Beer Marc D	Chief Executive Officer	M Exercise	2013-10-30	2013-10-31	40,000	$1.54	$61.6K	235,726	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	2,700	$89.85	$242.6K	201,026	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	200	$94.25	$18.9K	197,226	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	2,500	$91.21	$228.0K	198,526	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	1,200	$99.18	$119.0K	195,726	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	300	$95.90	$28.8K	196,926	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	700	$92.03	$64.4K	197,826	SEC↗
Beer Marc D	Chief Executive Officer	S Sale	2013-10-30	2013-10-31	400	$93.00	$37.2K	197,426	SEC↗
SMITH SANDFORD D	Director	M Exercise deriv	2013-10-29	2013-10-31	2,502	—	$0	8,569	SEC↗
SMITH SANDFORD D	Director	S Sale	2013-10-29	2013-10-31	2,502	$95.00	$237.7K	0	SEC↗
SMITH SANDFORD D	Director	M Exercise	2013-10-29	2013-10-31	2,502	$15.00	$37.5K	2,502	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2013-10-15	2013-10-16	2,000	—	$0	130,500	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-10-15	2013-10-16	1,000	$79.95	$80.0K	1,000	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-10-15	2013-10-16	1,000	$80.71	$80.7K	0	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2013-10-15	2013-10-16	2,000	$13.01	$26.0K	2,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise deriv	2013-10-07	2013-10-08	20,000	—	$0	80,000	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise deriv	2013-10-07	2013-10-08	3,500	—	$0	132,500	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2013-10-07	2013-10-08	7,092	$93.18	$660.8K	3,900	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2013-10-07	2013-10-08	9,008	$92.40	$832.3K	10,992	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	M Exercise	2013-10-07	2013-10-08	20,000	$13.01	$260.2K	20,000	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2013-10-07	2013-10-08	3,800	$94.82	$360.3K	100	SEC↗
Fraser Craig	Pres., US/Int. Comm. & Manuf	S Sale	2013-10-07	2013-10-08	100	$96.25	$9.6K	0	SEC↗
Sumeray Mark	Chief Medical Officer	S Sale	2013-10-07	2013-10-08	700	$94.81	$66.4K	0	SEC↗
Sumeray Mark	Chief Medical Officer	M Exercise	2013-10-07	2013-10-08	3,500	$13.01	$45.5K	3,500	SEC↗